Skip to main content
Equibles
HROW logo

HROW · Harrow, Inc.

Track HROW — free

Use HROW with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$38.78 -0.27 (-0.69%)
Russell 2000 member Rebalance outlook locked
Market Cap
$1.39B
Shares
37.49M

HROW metrics

76 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$39.05
Market cap
$1.39B

Price action

19 metrics
Price change (1W)
-10.5%
Price change (30D)
-5.4%
Price change (3M)
+12.5%
Price change (6M)
-4.2%
Price change (YTD)
-24.6%
Price change (1Y)
-5.2%
Trailing year
Price change (5Y)
+264.6%
52-week high
$54.80
52-week low
$29.03
Change from 52-week high
-32.5%
Change from 52-week low
+27.4%
Annualized volatility
64.9%
Beta
1.5
RSI (14D)
38.7
Price vs SMA 50
-10.0%
Price vs SMA 200
-10.5%
Avg volume (3M)
651,535
Relative volume
0.6
Average dollar volume
$26.26M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
37.49M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
5.0×
reciprocal yield 19.9%
P / book
91.2
reciprocal yield 1.1%
FCF yield
0.4%
TTM · current market cap
Buyback yield
—
P / FCF
276.3
reciprocal yield 0.4%
P / operating cash flow
221.7
reciprocal yield 0.5%
Earnings yield
-2.7%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
5.9×
reciprocal yield 17.0%
EV / revenue historical average (5Y)
5.7×
reciprocal yield 17.5%
EV / EBIT historical average (3Y)
365.3×
reciprocal yield 0.3%
EV / EBIT historical average (5Y)
277.1×
reciprocal yield 0.4%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
63.1×
reciprocal yield 1.6%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-11

Profitability

9 metrics
Gross margin
73.3%
Operating margin
-1.0%
Trailing 12 months
Net margin
-13.5%
Gross profit (TTM)
$201.96M
Operating profit (TTM)
−$2.75M
Net income (TTM)
−$37.23M
Trailing 12 months
Diluted EPS (TTM)
$-0.97
FCF margin
1.8%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$1.52

Growth

11 metrics
Revenue growth YoY
+10.9%
Year over year
Net income growth YoY
-445.7%
Revenue (TTM)
$275.59M
Trailing 12 months
EPS growth YoY
-453.8%
Shares change YoY
-3.9%
Year over year · fewer shares
Revenue CAGR (3Y)
+45.4%
Revenue CAGR (5Y)
+41.0%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-244.9%
Return on assets
-8.9%
Debt / equity
—
Current ratio
2.2
EBITDA (TTM)
−$1.33M
Free cash flow (TTM)
$5.02M
Quick ratio
2.1
Interest coverage
-0.1
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$83.89M
Total assets
$416.82M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$6.25M
Capital expenditures (TTM)
$1.24M
R&D (TTM)
$29.01M
SG&A (TTM)
$175.69M
Stock compensation (TTM)
$14.70M
R&D / revenue
10.5%
Stock compensation / revenue
5.3%

Ownership (13F)

3 metrics
13F filers
224
13F filer change QoQ
+3
Institutional ownership
62.2%

Short interest

3 metrics
Short interest
17.0%
Latest settlement · 10.3 days to cover
Days to cover
10.3d
Short-squeeze score
73 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$450,000
Insider-sentiment score
41 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1360214 CUSIP 415858109 13F (30d) 178 filings 174 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)